The case concerned a medical trial of Akero’s solely product, a drug candidate aimed toward treating a liver illness. It is the second time U.S. District Decide Yvonne Gonzalez Rogers has ordered dismissal.
Trending
- Electric car sales hit record high in September
- Why the Fujifilm GFX100RF Could Be the Ultimate Lightweight Medium Format Camera
- The America’s Best rebrand shows great vision
- GWR fined £1m over train passenger’s death in Bath
- Fortis gastroenterologist says include ‘jowar, bajra and ragi rotis’ in your diet; shares their amazing health benefits
- Here Are the Cable News Ratings for September 2025
- Rare West African Pygmy Hippos Welcomed at Michigan’s John Ball Zoo
- a $55bn bet on fandom
Latham Wins Dismissal of Securities Action Involving Liver Disease Drug Developer
